Oxford's Big Data Pioneer Inspires Students at Concordia Shanghai

Oxford's Big Data Pioneer Inspires Students at Concordia Shanghai

SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Concordia International School Shanghai had the honor of welcoming world-renowned scholar and "father of big data," Professor Viktor Mayer-Schönberger, to campus this November. The Oxford professor delivered a...

Metalpha Appoints New CFO

Metalpha Appoints New CFO

HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Metalpha Technology Holding Limited (Nasdaq: MATH) (the "Company" or "Metalpha"), a global digital asset-focused wealth management company, today announced the appointment of Mr. Pengyuan Fan as Chief...

Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage...

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage...

iQOO 13 unleashes the full potential of Snapdragon® 8 Elite with joint tuning for the ultimate mobile experience

iQOO 13 unleashes the full potential of Snapdragon® 8 Elite with joint tuning for the ultimate mobile experience

Simultaneously supported by iQOO ' s Q2 chip, iQOO 13 raises the performance bar with advanced speed, stability, imaging, and cooling for mobile users who expect more. DONGGUAN, China, Nov. 28, 2024 /PRNewswire/ -- iQOO, an independent sub-brand of...

New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List

New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...

Xinhua Silk Road: Multiple achievements made at promotion conference held in Shanghai

Xinhua Silk Road: Multiple achievements made at promotion conference held in Shanghai

BEIJING, Nov. 28, 2024 /PRNewswire/ -- A series of achievements was recently made at the Shanghai Jing'an "Global Service Provider Program" (GSPP) Promotion Conference and the 1st China Enterprise Globalization Development Professional Service...

Sungrow and Smart Commercial Solar Partner to Build Sustainable Energy Infrastructure for Leading Aged Care Provider, Opal HealthCare

Sungrow and Smart Commercial Solar Partner to Build Sustainable Energy Infrastructure for Leading Aged Care Provider, Opal HealthCare

SYDNEY, Nov. 28, 2024 /PRNewswire/ -- Sungrow, the global leading PV inverter and energy storage system provider, announced that its C&I solar solutions were selected by Smart Commercial Solar for their national Opal HealthCare clean energy...

ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA

ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA

Mok will be pivotal in solidifying Assembly's proposition and accelerating the agency's growth in North Asia SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- Assembly, a leading global omnichannel media agency, announced today the promotion of...

Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab

Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab

HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific...

  • 1
  • ...
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • ...
  • 105
  • menu
    menu